Exclusive Webinar :Don't miss the latest webinar on Global Investing with Passive Products on June 22, 11am
you are here: HomeNewsIndia

With 12,481 new cases and 347 deaths, Delhi's COVID-19 positivity rate dips below 18%

The number of coronavirus recoveries exceeded the number of new cases added in the past 24 hours in Delhi, with 13,583 COVID-19 patients recovering from the disease.

May 11, 2021 / 05:13 PM IST
Representative image

Representative image

Delhi recorded 12,481 fresh COVID-19 cases and 347 deaths in the past 24 hours. A Delhi state health department bulletin released on May 11 stated that the coronavirus positivity rate has dipped to 17.76 percent.

The number of coronavirus recoveries exceeded the number of new cases added in the past 24 hours in Delhi, with 13,583 COVID-19 patients recovering from the disease. A total of 12,44,880 COVID-19 patients have recovered in Delhi so far.

Now, the National Capital's total active coronavirus cases stand at 83,809 and the current COVID-19 death toll is 20,010.

Delhi has vaccinated 1,40,963 beneficiaries in the past 24 hours and the cumulative number of beneficiaries who have been vaccinated for the first and second dose stands at 31,09,903 and 9,08,460, respectively.

The Aam Aadmi Party (AAP) government led by Arvind Kejriwal has imposed a lockdown in Delhi, which will be in place till May 17. The Chief Minister of the state has said that the lockdown has been effective and coronavirus cases are on the decline.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

News agency ANI quoted Delhi Health Minister Satyendar Jain as saying on May 11: "In the last few days, positivity rate has declined from 36 percent to 19.1 percent with the caseload also going down from 28,000 per day to about 12,500. Till we reach a positivity rate at below five percent and caseload below 3000-4000 cases, we can't be at ease."

He added: "Demand for oxygen and beds is less now, but it is there. We have about 23,000 beds of which 20,000 are occupied. It is a huge number. Oxygen supply should continue otherwise it will be problematic. We are getting a little less than the requirement of 700 tonnes of liquid medical oxygen.

Follow our coverage of the coronavirus crisis here
Moneycontrol News
first published: May 11, 2021 04:18 pm

stay updated

Get Daily News on your Browser
Sections